Home / Market Reports / Medical Devices & Consumables / Global Bioabsorbable Eluting Coronary Stent System Market Growth 2024-2030

Global Bioabsorbable Eluting Coronary Stent System Market Growth 2024-2030

Global Bioabsorbable Eluting Coronary Stent System Market Growth 2024-2030

Product Code:1240284

Published Date: Nov 22,2024

Pages: 118

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Bioabsorbable Eluting Coronary Stent System market size is predicted to grow from US$ 5890 million in 2024 to US$ 7663 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.

The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.

United States market for Bioabsorbable Eluting Coronary Stent System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Bioabsorbable Eluting Coronary Stent System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Bioabsorbable Eluting Coronary Stent System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Bioabsorbable Eluting Coronary Stent System players cover Boston Scientific, Medtronic, Abbott, B.Braun, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Bioabsorbable Eluting Coronary Stent System Industry Forecast” looks at past sales and reviews total world Bioabsorbable Eluting Coronary Stent System sales in 2023, providing a comprehensive analysis by region and market sector of projected Bioabsorbable Eluting Coronary Stent System sales for 2024 through 2030. With Bioabsorbable Eluting Coronary Stent System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioabsorbable Eluting Coronary Stent System industry.

This Insight Report provides a comprehensive analysis of the global Bioabsorbable Eluting Coronary Stent System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioabsorbable Eluting Coronary Stent System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioabsorbable Eluting Coronary Stent System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioabsorbable Eluting Coronary Stent System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioabsorbable Eluting Coronary Stent System.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioabsorbable Eluting Coronary Stent System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Rapamycin Eluting Stent
    Everolimus Eluting Stent
    Others

Segmentation by Application:
    Hospitals
    Clinic
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Boston Scientific
    Medtronic
    Abbott
    B.Braun
    BD
    Biotronik AG
    Stentys SA
    Sino Medical
    Beijing ESSEN Technology
    Beijing Advanced Medical Technologies
    LifeTech Scientific Corporation
    MicroPort Scientific Corporation
    Yilson Medical Technology
    Lepu Medical Technology
    Shandong Hua'an Biotechnology

Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioabsorbable Eluting Coronary Stent System market?
What factors are driving Bioabsorbable Eluting Coronary Stent System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioabsorbable Eluting Coronary Stent System market opportunities vary by end market size?
How does Bioabsorbable Eluting Coronary Stent System break out by Type, by Application?